162 related articles for article (PubMed ID: 23183674)
21. Ablation of remaining functioning thyroid lobe with radioiodine after hemithyroidectomy for carcinoma.
Arad E; O'Mara RE; Wilson GA
Clin Nucl Med; 1993 Aug; 18(8):662-3. PubMed ID: 8403696
[TBL] [Abstract][Full Text] [Related]
22. Video-assisted thyroidectomy for papillary thyroid carcinoma.
Bellantone R; Lombardi CP; Raffaelli M; Alesina PF; De Crea C; Traini E; Salvatori M
Surg Endosc; 2003 Oct; 17(10):1604-8. PubMed ID: 12874681
[TBL] [Abstract][Full Text] [Related]
23. [Differentiated thyroid gland carcinoma in a scintigraphically hot thyroid nodule: diagnosis and interdisciplinary therapeutic management].
Stahl A; Hess U; Harms J; Zwicknagl M; Langhammer H
Wien Klin Wochenschr; 2002 Jun; 114(10-11):410-4. PubMed ID: 12708097
[TBL] [Abstract][Full Text] [Related]
24. Radioiodine ablation of residual tissue in thyroid cancer: relationship between administered activity, neck uptake and outcome.
Logue JP; Tsang RW; Brierley JD; Simpson WJ
Br J Radiol; 1994 Nov; 67(803):1127-31. PubMed ID: 7820407
[TBL] [Abstract][Full Text] [Related]
25. The British Thyroid Association guidelines for the management of thyroid cancer in adults.
Watkinson JC;
Nucl Med Commun; 2004 Sep; 25(9):897-900. PubMed ID: 15319594
[No Abstract] [Full Text] [Related]
26. Incidental multifocal papillary microcarcinomas of the thyroid: is subtotal thyroidectomy combined with radioiodine ablation enough?
Dietlein M; Luyken WA; Schicha H; Larena-Avellaneda A
Nucl Med Commun; 2005 Jan; 26(1):3-8. PubMed ID: 15604941
[TBL] [Abstract][Full Text] [Related]
27. Factors influencing radioiodine uptake after thyroid cancer surgery.
Bai JB; Shakerian R; Westcott JD; Lichtenstein M; Miller JA
ANZ J Surg; 2015; 85(7-8):572-7. PubMed ID: 23964714
[TBL] [Abstract][Full Text] [Related]
28. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).
Farahati J; Reiners C; Stuschke M; Müller SP; Stüben G; Sauerwein W; Sack H
Cancer; 1996 Jan; 77(1):172-80. PubMed ID: 8630926
[TBL] [Abstract][Full Text] [Related]
29. A prospective clinical trial to assess the efficacy of radioiodine ablation as an alternative to completion thyroidectomy in patients with differentiated thyroid cancer undergoing sub-total thyroidectomy.
Bal CS; Kumar A; Chandra P; Dwivedi SN; Pant GS
Acta Oncol; 2006; 45(8):1067-72. PubMed ID: 17118841
[TBL] [Abstract][Full Text] [Related]
30. The overuse of radioactive iodine in low-risk papillary thyroid cancer patients.
Moten AS; Zhao H; Willis AI
Surg Oncol; 2019 Jun; 29():184-189. PubMed ID: 31196486
[TBL] [Abstract][Full Text] [Related]
31. [Radioiodine therapy in differentiated thyroid gland carcinoma].
Schicha H; Dietlein M
Zentralbl Chir; 1997; 122(4):266-73. PubMed ID: 9221637
[TBL] [Abstract][Full Text] [Related]
32. Advances in the medical management of differentiated thyroid carcinoma and their impact on the surgical approach.
Van den Bruel A; Vauterin T; Poorten VV; Decallonne B
Acta Chir Belg; 2007 Jun; 107(3):271-8. PubMed ID: 17685252
[TBL] [Abstract][Full Text] [Related]
33. [Diagnosis, treatment and follow-up in the case of differentiated thyroid cancer].
Lind P; Igerc I; Kohlfürst S
Wien Med Wochenschr; 2005 Oct; 155(19-20):429-35. PubMed ID: 16424998
[TBL] [Abstract][Full Text] [Related]
34. [Differentiated thyroid carcinoma in children and adolescents: therapeutic strategy according to clinic presentation].
Causeret S; Lifante JC; Borson-Chazot F; Varcus F; Berger N; Peix JL
Ann Chir; 2004; 129(6-7):359-64. PubMed ID: 15297226
[TBL] [Abstract][Full Text] [Related]
35. Thyroid ablation with 1.1 GBq (30 mCi) iodine-131 in patients with papillary thyroid carcinoma at intermediate risk for recurrence.
Rosário PW; Calsolari MR
Thyroid; 2014 May; 24(5):826-31. PubMed ID: 24283207
[TBL] [Abstract][Full Text] [Related]
36. Impact of early vs late postoperative radioiodine remnant ablation on final outcome in patients with low-risk well-differentiated thyroid cancer.
Tsirona S; Vlassopoulou V; Tzanela M; Rondogianni P; Ioannidis G; Vassilopoulos C; Botoula E; Trivizas P; Datseris I; Tsagarakis S
Clin Endocrinol (Oxf); 2014 Mar; 80(3):459-63. PubMed ID: 23895145
[TBL] [Abstract][Full Text] [Related]
37. Low-risk thyroid cancer, surgical training, and radioactive iodine.
Shaha AR
Ann Surg Oncol; 2013 Mar; 20(3):703-4. PubMed ID: 23250737
[No Abstract] [Full Text] [Related]
38. Quantitative approach to radioiodine ablation of thyroid remnants following surgery for thyroid cancer.
Hadjieva T
Radiobiol Radiother (Berl); 1985; 26(6):819-23. PubMed ID: 4095270
[No Abstract] [Full Text] [Related]
39. Radioiodine therapy for papillary and follicular thyroid carcinoma.
Klain M; Ricard M; Leboulleux S; Baudin E; Schlumberger M
Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S479-85. PubMed ID: 12192549
[TBL] [Abstract][Full Text] [Related]
40. The role of total thyroidectomy in the management of differentiated thyroid cancer.
Stephenson BM; Wheeler MH; Clark OH
Curr Opin Gen Surg; 1994; ():53-9. PubMed ID: 7584009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
